Literature DB >> 13704490

Spironolactone in hypertensive patients. Oligemic and antihypertensive effects.

A J GEORGOPOULOS, H DUSTAN, I H PAGE.   

Abstract

Entities:  

Keywords:  ALDOSTERONE/antagonists; BLOOD VOLUME/pharmacology; DIURETICS/therapy; HYPERTENSION/therapy

Mesh：

Substances：

Year:  1961        PMID： 13704490     DOI： 10.1001/archinte.1961.03620090061007

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  3 in total

1.  Paradoxical potassium excretion in response to aldosterone antagonists.

Authors:  L E Ramsay; I R Harrison; J R Shelton; M J Tidd
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

2.  Spironolactone.

Authors: 
Journal:  Br Med J       Date:  1967-06-17

3.  Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.

Authors:  J J Brown; D L Davies; J B Ferriss; R Fraser; E Haywood; A F Lever; J I Robertson
Journal:  Br Med J       Date:  1972-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.